Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 5. FX-9 does not inhibit CK2 activity. Recombinant human CK2 was incubated with CK2α1 substrate, ATP and increasing concentrations of FX-9 or CX-4945. Reduction of CK2 enzyme activity was induced with 0.1 μM CX-4945. No changes of CK2 enzyme activity were observed with FX-9. Results are displayed as mean and standard deviation of three technical replicates of one experiment.
Biomol Ther 2019;27:492~501 https://doi.org/10.4062/biomolther.2018.199
© Biomolecules & Therapeutics